Toyota|$17.71 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.26 (¥4,353)+1.68%▲ (in JPY terms)
SoftBank|$22.21 (¥3,547)-5.11%▼ (in JPY terms)
MUFG|$21.76 (¥3,475)-0.66%▼ (in JPY terms)
Keyence|$467.04 (¥74,580)-0.60%▼ (in JPY terms)
Nintendo|$54.94 (¥8,773)+2.45%▲ (in JPY terms)
NTT|$1.05 (¥168)+0.54%▲ (in JPY terms)
Takeda|$43.37 (¥6,926)+1.48%▲ (in JPY terms)
Tokyo Electron|$59.25 (¥9,461)+1.69%▲ (in JPY terms)
Recruit|$109.97 (¥17,560)+5.06%▲ (in JPY terms)
ITOCHU|$15.10 (¥2,412)-0.02%▼ (in JPY terms)
Honda|$11.53 (¥1,842)+1.66%▲ (in JPY terms)
Shin-Etsu|$35.72 (¥5,704)-1.50%▼ (in JPY terms)
Tokio Marine|$3.74 (¥597)+0.56%▲ (in JPY terms)
Fast Retailing|$514.26 (¥82,120)+2.41%▲ (in JPY terms)
Toyota|$17.71 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.26 (¥4,353)+1.68%▲ (in JPY terms)
SoftBank|$22.21 (¥3,547)-5.11%▼ (in JPY terms)
MUFG|$21.76 (¥3,475)-0.66%▼ (in JPY terms)
Keyence|$467.04 (¥74,580)-0.60%▼ (in JPY terms)
Nintendo|$54.94 (¥8,773)+2.45%▲ (in JPY terms)
NTT|$1.05 (¥168)+0.54%▲ (in JPY terms)
Takeda|$43.37 (¥6,926)+1.48%▲ (in JPY terms)
Tokyo Electron|$59.25 (¥9,461)+1.69%▲ (in JPY terms)
Recruit|$109.97 (¥17,560)+5.06%▲ (in JPY terms)
ITOCHU|$15.10 (¥2,412)-0.02%▼ (in JPY terms)
Honda|$11.53 (¥1,842)+1.66%▲ (in JPY terms)
Shin-Etsu|$35.72 (¥5,704)-1.50%▼ (in JPY terms)
Tokio Marine|$3.74 (¥597)+0.56%▲ (in JPY terms)
Fast Retailing|$514.26 (¥82,120)+2.41%▲ (in JPY terms)

admin

2026-07-13 Eisai Co.,Ltd. “Clinical data supporting the efficacy and safety of the "Rekenbi®" subcutaneous autoinjector, comparable to intravenous formulations, in early Alzheimer's disease were presented at AAIC 2026. New clinical and real-world data support a subcutaneous treatment pathway from initial therapy to ongoing therapy, contributing to improved convenience for patients and care partners.”

by

2026-07-13 Eisai Co.,Ltd. “Clinical data supporting the efficacy and safety of the "Rekenbi®" … 続きを読む

2026-07-13 Astellas Pharma Inc. “The antibody-drug conjugate PADCEV™ (enfortumab vedotin) has received approval in the United States as neoadjuvant and adjuvant therapy for muscle-invasive bladder cancer, regardless of whether cisplatin is indicated, in combination with pembrolizumab.”

by

2026-07-13 Astellas Pharma Inc. “The antibody-drug conjugate PADCEV™ (enfortumab vedotin) has received a … 続きを読む

2026-07-13 Mitsubishi Chemical Group Corporation “Announcement 2026/07/13 NEW Mitsubishi Chemical's "Girls STEM Integrated Development Initiative" has won an award at the "HR Awards 2026" sponsored by the Ministry of Health, Labour and Welfare and the Japan Human Resources Department.”

by

2026-07-13 Mitsubishi Chemical Group Corporation “Announcement 2026/07/13 NEW Mitsubishi Chemical's … 続きを読む

2026-07-13 Resonac Holdings Corporation “Resona's learning event, "Learning Fest," has been awarded in the Corporate Human Resources category of the "HR Awards 2026"—with approximately 1,500 participants in total, the initiative was recognized for fostering autonomous learning and interaction.”

by

2026-07-13 Resonac Holdings Corporation “Resona's learning event, "Learning Fest," has bee … 続きを読む

Sister site: Lagrange Financial News (Japanese-language)
Contact